MAM
DGX icon

Marquette Asset Management’s Quest Diagnostics DGX Stock Holding History

Marquette Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27K Hold
6
– – ﹤0.01% 692
2026
Q1 		$1.18K Buy
6
+3
+100% +$583 ﹤0.01% 651
2025
Q4 		$521 Sell
3
-9
-75% -$1.64K ﹤0.01% 652
2025
Q3 		$2.29K Buy
+12
New +$2.13K ﹤0.01% 511

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Marquette Asset Management's DGX Position: Q2 2026 in Review

Marquette Asset Management held its Quest Diagnostics (DGX) position steady in Q2 2026 at 6 shares worth $1.27K. The position accounts for ﹤0.01% of the portfolio, ranked #692.

Marquette Asset Management first reported a position in DGX in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.29K in Q3 2025. 629 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Marquette Asset Management held 6 shares of Quest Diagnostics worth $1.27K as of Q2 2026.
  • Marquette Asset Management left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up ﹤0.01% of Marquette Asset Management's portfolio in Q2 2026, its #692 holding.
  • Marquette Asset Management first reported a position in Quest Diagnostics in Q3 2025 and has held it in 4 quarters since.
  • Marquette Asset Management's Quest Diagnostics position peaked at $2.29K in Q3 2025.
  • 629 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.